Open official notice

Methylprednisolone sodium succinate for injection, usp, 500 mg* vial, Rx only, mfd by: hikma farmaceutica (portugal), sa; dist by

Official notice

29 Jan 2020

RecallScope risk estimate:LowFDA

An official FDA notice concerns Methylprednisolone sodium succinate for injection, usp, 500 mg* vial, Rx only, mfd by: hikma farmaceutica (portugal), sa; dist by. Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol. Published 2020-01-29.

What to do now

This recall has been terminated. See the official FDA notice for the latest status.

Units affected

4,840

Recall number

D-0801-2020

Official notice

2020-01-29

The hazard

Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol.

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Event Ids

84676

Recall Numbers

D-0801-2020

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only, Mfd by: HIKMA FARMACEUTICA (PORTUGAL), SA; Dist by: WEST-WARD, Eatontown, NJ 07724, NDC 0143-9850-01.

Units affected

4,840

Hazard

Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States

Affected area 1

US · United States

Company & contacts

Manufacturer

Hikma Pharmaceuticals USA Inc.

Phone

Not provided

Brand: Hikma Pharmaceuticals. Contact: Hikma Pharmaceuticals USA Inc..

Source & status

Source

Tier

official

Category

Health

Official classification

Class III

Recall details

Recall number

D-0801-2020

Event ID

84676

Units affected

4,840

Status

terminated

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 29 Jan 2020. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button